These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 16552756)
1. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease. Deng H; Xie W; Guo Y; Le W; Jankovic J Mov Disord; 2006 May; 21(5):728-9. PubMed ID: 16552756 [No Abstract] [Full Text] [Related]
2. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335 [TBL] [Abstract][Full Text] [Related]
3. Failure to find alpha-synuclein gene dosage changes in 190 patients with familial Parkinson disease. Gispert S; Trenkwalder C; Mota-Vieira L; Kostic V; Auburger G Arch Neurol; 2005 Jan; 62(1):96-8. PubMed ID: 15642855 [TBL] [Abstract][Full Text] [Related]
4. alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394 [TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease. Hope AD; Myhre R; Kachergus J; Lincoln S; Bisceglio G; Hulihan M; Farrer MJ Neurosci Lett; 2004 Aug; 367(1):97-100. PubMed ID: 15308306 [TBL] [Abstract][Full Text] [Related]
7. [Relationship between alpha-synuclein and Parkinson's disease]. Nishioka K; Hattori N Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118 [TBL] [Abstract][Full Text] [Related]
8. alpha-Synuclein locus triplication causes Parkinson's disease. Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171 [No Abstract] [Full Text] [Related]
9. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. Fuchs J; Tichopad A; Golub Y; Munz M; Schweitzer KJ; Wolf B; Berg D; Mueller JC; Gasser T FASEB J; 2008 May; 22(5):1327-34. PubMed ID: 18162487 [TBL] [Abstract][Full Text] [Related]
10. Gene dosage and pathogenesis of Parkinson's disease. Eriksen JL; Przedborski S; Petrucelli L Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766 [TBL] [Abstract][Full Text] [Related]
11. Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication. Orimo S; Uchihara T; Nakamura A; Mori F; Ikeuchi T; Onodera O; Nishizawa M; Ishikawa A; Kakita A; Wakabayashi K; Takahashi H Acta Neuropathol; 2008 Nov; 116(5):575-7. PubMed ID: 18751989 [No Abstract] [Full Text] [Related]
12. Alpha-synuclein mRNA expression in sporadic Parkinson's disease. Tan EK; Chandran VR; Fook-Chong S; Shen H; Yew K; Teoh ML; Yuen Y; Zhao Y Mov Disord; 2005 May; 20(5):620-3. PubMed ID: 15719423 [TBL] [Abstract][Full Text] [Related]
13. Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease. Voutsinas GE; Stavrou EF; Karousos G; Dasoula A; Papachatzopoulou A; Syrrou M; Verkerk AJ; van der Spek P; Patrinos GP; Stöger R; Athanassiadou A Hum Mutat; 2010 Jun; 31(6):685-91. PubMed ID: 20340137 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of the alpha-synuclein gene dosage variation associated with autosomal dominant form of ParkinsonTs disease]. Semenova EV; Shadrina MI; Slominskiĭ PA; Illarioshkin SN; Bagyeva GKh; Karabanov AV; Ivanova-Smolenskaia IA; Limborskaia SA Genetika; 2009 Apr; 45(4):573-6. PubMed ID: 19507712 [TBL] [Abstract][Full Text] [Related]
15. Risk and protective haplotypes of the alpha-synuclein gene associated with Parkinson's disease differentially affect cognitive sequence learning. Kéri S; Nagy H; Myers CE; Benedek G; Shohamy D; Gluck MA Genes Brain Behav; 2008 Feb; 7(1):31-6. PubMed ID: 17451452 [TBL] [Abstract][Full Text] [Related]
16. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Ikeuchi T; Kakita A; Shiga A; Kasuga K; Kaneko H; Tan CF; Idezuka J; Wakabayashi K; Onodera O; Iwatsubo T; Nishizawa M; Takahashi H; Ishikawa A Arch Neurol; 2008 Apr; 65(4):514-9. PubMed ID: 18413475 [TBL] [Abstract][Full Text] [Related]
17. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population. Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051 [TBL] [Abstract][Full Text] [Related]
18. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease. Häbig K; Walter M; Stappert H; Riess O; Bonin M Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032 [TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients. Berg D; Niwar M; Maass S; Zimprich A; Möller JC; Wuellner U; Schmitz-Hübsch T; Klein C; Tan EK; Schöls L; Marsh L; Dawson TM; Janetzky B; Müller T; Woitalla D; Kostic V; Pramstaller PP; Oertel WH; Bauer P; Krueger R; Gasser T; Riess O Mov Disord; 2005 Sep; 20(9):1191-4. PubMed ID: 15895422 [TBL] [Abstract][Full Text] [Related]